In the STEP 1 and STEP 3 trials, participants with a mean BMI of 38 showed around 15% weight loss after 68 weeks treatment with 2.4mg semaglutide
Unlike other medications utilized in the management of diabetes, but like the information on SGLT2 inhibitors, there is little evidence on the association of that pharmacologic group with gastrointestinal symptomatology.42 Sodium-glucose cotransporter type 2 inhibitors Sodium-glucose cotransporter type 1 (SGLT1) and type 2 (SGLT2) are members of the SLC5 gene family, a subdivision of a superfamily of sodium cotransporters
When you add obesity medicine training and certification, and when youre working within a functional medicine framework that addresses nutrition, lifestyle, and metabolic health comprehensively, prescribing GLP-1s makes complete sense
Possible causes include: Graves disease Thyroid nodules (goiter) Thyroiditis Iodine supplementation Drugs such as amiodarone Thyroid cancer Each of these types of hyperthyroidism has a unique cause, which should be addressed to normalize the thyroid gland's function